Point72 Hong Kong’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
Point72 Hong Kong's NVAX Position: Q2 2021 in Review
Point72 Hong Kong sold out of Novavax (NVAX) in Q2 2021, closing a stake of 204 shares — an estimated $37K sold.
Point72 Hong Kong first reported a position in NVAX in Q3 2016 and held it in 7 quarters. The position peaked at $103K in Q3 2020. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.
- Point72 Hong Kong reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
- Point72 Hong Kong sold 204 Novavax shares in Q2 2021, an estimated $37K.
- Point72 Hong Kong first reported a position in Novavax in Q3 2016 and held it in 7 quarters.
- Point72 Hong Kong's Novavax position peaked at $103K in Q3 2020.
- 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.
Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.